Huntington Bancshares (NASDAQ:HBAN) CEO Stephen Steinour acquired 10,750 shares of the stock on the open market in a transaction that occurred on Thursday, April 24th. The shares were purchased at an average price of $9.32 per share, for a total transaction of $100,190.00.Huntington Bancshares Incorporated (NASDAQ:HBAN) shares after opening at $9.15 moved to $9.16 on last trade day and at the end of the day closed at $9.05. Company price to sales ratio in past twelve months was calculated as 4.01and price to cash ratio as 6.90. Huntington Bancshares Incorporated (NASDAQ:HBAN) showed a negative weekly performance of -3.42%.
American Realty Capital Properties (NASDAQ:ARCP) Director Edward Jr. Weil bought 7,500 shares of American Realty Capital Properties stock in a transaction dated Monday, April 21st. The shares were purchased at an average price of $13.28 per share, for a total transaction of $99,600.00. Following the completion of the purchase, the director now directly owns 5,086 shares in the company, valued at approximately $67,542. American Realty Capital Properties Inc (NASDAQ:ARCP) shares advanced 2.46% in last trading session and ended the day on $12.93. ARCP return on equity ratio is recorded as -31.80% and its return on assets is -11.90%. American Realty Capital Properties Inc (NASDAQ:ARCP) yearly performance is -15.27%.
Aaron’s, Inc. (NYSE:AAN) CEO John W Robinson acquired 50,000 shares of the stock on the open market in a transaction that occurred on Thursday, April 28th. The shares were purchased at an average price of $ 28.96per share, for a total transaction of $ 1,448,000.00. Aaron’s, Inc. (NYSE:AAN) shares moved down -0.55% in last trading session and was closed at $29.11 while trading in range of $28.96 – $29.39 – Aaron’s, Inc. (NYSE:AAN) year to date (YTD) performance is -0.92%.
Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 36,200 shares of Opko Health stock on the open market in a transaction dated Friday, April 25th. The stock was purchased at an average cost of $8.04 per share, for a total transaction of $291,048.00. Opko Health Inc. (NYSE:OPK) on last trading day company shares ended up $8.31. Opko Health Inc. (NYSE:OPK) distance from 50-day simple moving average (SMA50) is -8.18%. Analysts mean target price for the company is $12.50.